BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32145106)

  • 1. Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?
    Frew JW; Grand D; Navrazhina K; Krueger JG
    Exp Dermatol; 2020 May; 29(5):509-515. PubMed ID: 32145106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
    Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
    Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
    Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.
    Witte-Händel E; Wolk K; Tsaousi A; Irmer ML; Mößner R; Shomroni O; Lingner T; Witte K; Kunkel D; Salinas G; Jodl S; Schmidt N; Sterry W; Volk HD; Giamarellos-Bourboulis EJ; Pokrywka A; Döcke WD; Schneider-Burrus S; Sabat R
    J Invest Dermatol; 2019 Jun; 139(6):1294-1305. PubMed ID: 30528824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa.
    Byrd AS; Carmona-Rivera C; O'Neil LJ; Carlucci PM; Cisar C; Rosenberg AZ; Kerns ML; Caffrey JA; Milner SM; Sacks JM; Aliu O; Broderick KP; Reichner JS; Miller LS; Kang S; Robinson WH; Okoye GA; Kaplan MJ
    Sci Transl Med; 2019 Sep; 11(508):. PubMed ID: 31484788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa.
    Lowe MM; Cohen JN; Moss MI; Clancy S; Adler JP; Yates AE; Naik HB; Yadav R; Pauli M; Taylor I; McKay A; Harris H; Kim E; Hansen SL; Rosenblum MD; Moreau JM
    JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38113104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
    Sabat R; Šimaitė D; Gudjonsson JE; Brembach TC; Witte K; Krause T; Kokolakis G; Bartnik E; Nikolaou C; Rill N; Coulibaly B; Levin C; Herrmann M; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Wolk K
    J Allergy Clin Immunol; 2023 Apr; 151(4):1015-1026. PubMed ID: 36481267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What causes hidradenitis suppurativa ?-15 years after.
    Zouboulis CC; Benhadou F; Byrd AS; Chandran NS; Giamarellos-Bourboulis EJ; Fabbrocini G; Frew JW; Fujita H; González-López MA; Guillem P; Gulliver WPF; Hamzavi I; Hayran Y; Hórvath B; Hüe S; Hunger RE; Ingram JR; Jemec GBE; Ju Q; Kimball AB; Kirby JS; Konstantinou MP; Lowes MA; MacLeod AS; Martorell A; Marzano AV; Matusiak Ł; Nassif A; Nikiphorou E; Nikolakis G; Nogueira da Costa A; Okun MM; Orenstein LAV; Pascual JC; Paus R; Perin B; Prens EP; Röhn TA; Szegedi A; Szepietowski JC; Tzellos T; Wang B; van der Zee HH
    Exp Dermatol; 2020 Dec; 29(12):1154-1170. PubMed ID: 33058306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis.
    Jones D; Banerjee A; Berger PZ; Gross A; McNish S; Amdur R; Shanmugam VK
    Immunol Invest; 2018 Jan; 47(1):57-70. PubMed ID: 28972431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities.
    Melnik BC; John SM; Chen W; Plewig G
    Br J Dermatol; 2018 Aug; 179(2):260-272. PubMed ID: 29573406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.
    Dréno B; Khammari A; Brocard A; Moyse D; Blouin E; Guillet G; Léonard F; Knol AC
    Arch Dermatol; 2012 Feb; 148(2):182-6. PubMed ID: 22004878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.
    Frew JW; Navrazhina K; Marohn M; Lu PC; Krueger JG
    Exp Dermatol; 2019 Aug; 28(8):886-891. PubMed ID: 31140657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
    Fletcher JM; Moran B; Petrasca A; Smith CM
    Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
    Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
    Shah A; Alhusayen R; Amini-Nik S
    Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
    Negus D; Ahn C; Huang W
    Expert Rev Clin Immunol; 2018 Apr; 14(4):275-283. PubMed ID: 29509041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriology of hidradenitis suppurativa/acne inversa: A review.
    Nikolakis G; Join-Lambert O; Karagiannidis I; Guet-Revillet H; Zouboulis CC; Nassif A
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.